A Phase Ib/II Study of the Safety and Immunogenicity of the Candidate Rabies Vaccine ChAdOx2 RabG
A Phase Ib/II Study of the Safety and Immunogenicity of the Candidate Rabies Vaccine ChAdOx2 RabG
Active, not recruiting · NCT04270838 · Registry updated 2025-11-18Clinical trials
Swipe the table sideways for more columns.
| Trial | Conditions | Status | Phase | Updated | More info | NCT ID |
|---|---|---|---|---|---|---|
| A Phase Ib/II Study of the Safety and Immunogenicity of the Candidate Rabies Vaccine ChAdOx2 RabG | Infections, Mononegavirales infectious disease, RNA Virus Infections, Rhabdoviridae infectious disease, rabies, viral infectious disease | Active, not recruiting | Phase 1 / Phase 2 | 2025-11-18 | NCT04270838 |
2 results · Page 1 of 1
Organizations
Swipe the table sideways for more columns.
| Organizations | Linked trials |
|---|---|
| Ifakara Health Institute | 7 |
| University of Oxford | 213 |
1 results · Page 1 of 1
Research sites
Swipe the table sideways for more columns.
| Research sites | City | Country | Linked trials |
|---|---|---|---|
| IHI Clinical Trial Facility | Bagamoyo | Tanzania | 1 |